A Shot in the Arm: Patent Waiver to Boost Vaccine Equity
These quotes have been selected from the article “COVID-19 Vaccine Accessibility: Impasse in the World Trade Organization” by Amarjit Bhullar
The article makes the case for expediting the patent waiver procedure at the World Trade Organization. In June 2022, the WTO finally reached an agreement to a partial patent waiver to boost the production of COVID-19 vaccines with some seeing it as too little, too late. With the recent filing of a lawsuit by Moderna against its rival Pfizer and BioNTech claiming patent infringement over the mRNA technology used to produce many of the COVID-19 vaccines, the world is gearing up for renewed debates over the question of patents and their impact on the future of public health.